XML 28 R9.htm IDEA: XBRL DOCUMENT
v3.22.4

Consolidated Financial Statements Details | 12 Months Ended
--- | ---
Dec. 31, 2022
Consolidated Financial Statements Detail |
Consolidated Financial Statements Detail | 3. Consolidated Financial Statement Detail Equity Securities As of December 31, 2022 and 2021, equity securities consisted of an investment in Rezolute’s common stock of $0.3 million and $0.8 million, respectively (Note 4). For the years ended December 31, 2022 and 2021, the Company recognized a loss of $0.4 million and $0.9 million, respectively, due to the change in fair value of its investment in Rezolute’s common stock in the other income (expense), net line item of the consolidated statements of operations and comprehensive (loss) income. Intangible assets, net The following table summarizes cost, accumulated amortization, and net carrying value of the intangible assets as of December 31, 2022 (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Accumulated | ​ | Net Carrying
​ | ​ | Cost | ​ | Amortization | ​ | Value
As of December 31, 2022 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Ebopiprant IP (Note 4) | ​ | $ | 15,247 | ​ | $ | 97 | ​ | $ | 15,150
Total intangible assets | ​ | $ | 15,247 | ​ | $ | 97 | ​ | $ | 15,150
​ The remaining life of the intangible assets is 16.9 years. The following table presents the projected amortization expense for the next five years (in thousands): ​
​ | ​ | ​ | ​
​ | ​ | Intangible Asset
​ |  | Amortization
​ |  | ​ | ​
2023 | ​ | $ | 897
2024 | ​ |  | 897
2025 | ​ |  | 897
2026 | ​ | ​ | 897
2027 | ​ | ​ | 897
Total | ​ | $ | 4,485
​ Accrued and Other Liabilities Accrued and other liabilities consisted of the following (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, | ​ | December 31,
​ |  | 2022 |  | 2021
Accrued payroll and benefits | ​ |  | 1,449 | ​ |  | 135
Accrued legal and accounting fees | ​ | ​ | 867 | ​ | ​ | 295
Accrued incentive compensation | ​ | ​ | 562 | ​ | ​ | 55
Other accrued liabilities | ​ | ​ | 40 | ​ | ​ | 40
Total | ​ | $ | 2,918 | ​ | $ | 525
​

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Consolidated financial statement detail. + References No definition available. + Details
Name: | xoma_ConsolidatedFinancialStatementDetailAbstract
Namespace Prefix: | xoma_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration